Dergiler / Turkish journal of nephrology (Online) / 2022 / Cilt: 31 - Sayı: 2

Pneumococcal and Influenza Vaccines in Dialysis Patients: Vaccination Information, Rates, and Patient Awareness

Sayfa
165–170
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Although the level of patient knowledge was low for both vaccines, patients were more aware of the influenza vaccine.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Pneumococcal and influenza vaccination rates are still far below the desired levels in dialysis patients.
📊
Temel Bulgular & Veri:We aimed to determine the pneumococcal and influenza vaccination information, rates, and knowledge levels of dialysis patients.
💡
Sonuç & Katkı:Although the level of patient knowledge was low for both vaccines, patients were more aware of the influenza vaccine.
🔬Tür:Uygulamalı Anket & Alan Araştırması
📍Kapsam:2020 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Pneumococcal and influenza vaccination rates are still far below the desired levels in dialysis patients. We aimed to determine the pneumococcal and influenza vaccination information, rates, and knowledge levels of dialysis patients. Methods: The study is a descriptive cross-sectional study in which 307 dialysis patients between 2020 and 2021 were analyzed retrospectively. Demographic characteristics of all patients and vaccination information were obtained from the faceto- face questionnaire and hospital medical records. Results: Of the participants, 52.4% were males, and the mean age was 56 ± 15.45 years. The pneumococcal vaccination rate was 37.1%, and the influenza vaccination rate was 58.6%. Of 114 patients who had received a pneumococcal vaccine, 91.2% had received a single dose of the vaccine. While the type of vaccine could not be determined in 86.8% of the patients in this group, the rate of vaccination with the 2 types of the pneumococcal vaccine was only 8.8%. Annual vaccination was given to all those who were vaccinated against influenza. In the whole group, the rate of those who had never heard of the pneumococcal vaccine was 24.4%, while this rate was 6.5% for the influenza vaccine. The patients had a very low level of knowledge of both vaccines (41% and 53.7%, respectively). Conclusion: Pneumococcal and influenza vaccination rate of dialysis patients was low. İnfluenza vaccination had been performed in compliance with the recommended scheme, but the doses of the pneumococcal vaccine were incomplete. Although the level of patient knowledge was low for both vaccines, patients were more aware of the influenza vaccine.

🔖

Bu Makaleye Atıf Yap

KARA, S., ORUÇ, E., TORUN, D., AKÇAY, M. Ş., HABEŞOĞLU, M. A. (2022). Pneumococcal and Influenza Vaccines in Dialysis Patients: Vaccination Information, Rates, and Patient Awareness. Turkish journal of nephrology (Online), Cilt: 31 - Sayı: 2, 165–170. https://ajindex.com/articles/606934

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Haddiya I. Current knowledge of vaccinations in chronic kidney disease patients. Int J Nephrol Renovasc Dis. 2020
  2. [CrossRef] 2. Reddy S, Chitturi C, Yee J. Vaccination in chronic kidney disease. Adv Chronic Kidney Dis. 2019
  3. 26(1):72-78. [CrossRef] 3. Naqvi SB, Collins AJ. Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis. 2006
  4. 13(3):199-204. [CrossRef] 4. Kosmadakis G, Albaret J, Correia EDC, Somda F, Aguilera D. Vaccination practices in dialysis patients: a narrative review. Semin Dial. 2018
  5. 31(5):507-518. [CrossRef] 5. Ventola CL. Immunization in the United States: recommendations, barriers, and measures to improve compliance. Part 2: adult vaccinations. P T. 2016
  6. 41(8):492-506. 6. Krueger KM, Ison MG, Ghossein C. Practical guide to vaccination in all stages of CKD, including patients treated by dialysis or kidney transplantation. Am J Kidney Dis. 2020
  7. 75(3):417-425. [CrossRef] 7. Bond TC, Patel PR, Krisher J, et al. Association of standing-order policies with vaccination rates in dialysis clinics: a US-based crosssectional study. Am J Kidney Dis. 2009
  8. 54(1):86-94. [CrossRef] 8. Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012
  9. 61(40):816-819. 9. Republic of Turkey Ministry of Health, Public Health Institution. Risk group vaccinations. Pneumococcal and influenza vaccine application scheme. Available at: https://as ırehb eri.s aglik.gov. tr/ ge nelge ler/r isk-g rubu- genel gesi, Accessed May 26, 2021. 10. EKMUD Guides. Adult Immunization Guideline 2019. Infectious Diseases and Clinical Microbiology Specialty Society of Turkey (EKMUD). 2019. Available at: [CrossRef]. 11. Rodríguez MA, González AV, Gavín MA, et al. Invasive pneumococcal disease: association between serotype, clinical presentation, and lethality. Vaccine. 2011
  10. 29(34):5740-5746. [CrossRef] 12. Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest. 2001
  11. 120(6):1883- 1887. [CrossRef] 13. Bonten MJ, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015
  12. 372(12):1114-1125. [CrossRef] 14. Vadlamudi NK, Parhar K, Altre Malana KL, Kang A, Marra F. Immunogenicity and safety of the 13-valent p